The fund???s first investment is in SetPoint Medical, a Valencia, California-based company, which has developed proprietary implantable neuromodulation devices that stimulate the body???s vagus nerve to treat inflammatory diseases, such as Crohn???s disease and rheumatoid arthritis (2, 3).